EXEL Industries SA

Informe acción ENXTPA:EXE

Capitalización de mercado: €337.2m

EXEL Industries Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de EXEL Industries de 5.7% y 2.2% por año respectivamente. Se prevé que el BPA crezca en un 4.9% al año. Se espera que la rentabilidad financiera sea de 9.2% en 3 años.

Información clave

5.7%

Tasa de crecimiento de los beneficios

4.9%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Machinery43.0%
Tasa de crecimiento de los ingresos2.2%
Rentabilidad financiera futura9.2%
Cobertura de analistas

Low

Última actualización05 Sep 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

EXEL Industries (EPA:EXE) Has More To Do To Multiply In Value Going Forward

Jun 15
EXEL Industries (EPA:EXE) Has More To Do To Multiply In Value Going Forward

EXEL Industries (EPA:EXE) Will Pay A Larger Dividend Than Last Year At €1.57

Jan 30
EXEL Industries (EPA:EXE) Will Pay A Larger Dividend Than Last Year At €1.57

Is EXEL Industries (EPA:EXE) A Risky Investment?

Jan 28
Is EXEL Industries (EPA:EXE) A Risky Investment?

Be Wary Of EXEL Industries (EPA:EXE) And Its Returns On Capital

Dec 22
Be Wary Of EXEL Industries (EPA:EXE) And Its Returns On Capital

An Intrinsic Calculation For EXEL Industries SA (EPA:EXE) Suggests It's 37% Undervalued

Nov 22
An Intrinsic Calculation For EXEL Industries SA (EPA:EXE) Suggests It's 37% Undervalued

EXEL Industries (EPA:EXE) Is Reducing Its Dividend To €1.05

Jan 05
EXEL Industries (EPA:EXE) Is Reducing Its Dividend To €1.05

EXEL Industries (EPA:EXE) Will Be Hoping To Turn Its Returns On Capital Around

Oct 04
EXEL Industries (EPA:EXE) Will Be Hoping To Turn Its Returns On Capital Around

Is It Too Late To Consider Buying EXEL Industries SA (EPA:EXE)?

Mar 24
Is It Too Late To Consider Buying EXEL Industries SA (EPA:EXE)?

EXEL Industries (EPA:EXE) Has More To Do To Multiply In Value Going Forward

Dec 08
EXEL Industries (EPA:EXE) Has More To Do To Multiply In Value Going Forward

Is It Time To Consider Buying EXEL Industries SA (EPA:EXE)?

Nov 01
Is It Time To Consider Buying EXEL Industries SA (EPA:EXE)?

Does EXEL Industries (EPA:EXE) Have A Healthy Balance Sheet?

Jul 12
Does EXEL Industries (EPA:EXE) Have A Healthy Balance Sheet?

EXEL Industries (EPA:EXE) Has Some Difficulty Using Its Capital Effectively

May 31
EXEL Industries (EPA:EXE) Has Some Difficulty Using Its Capital Effectively

At €67.80, Is EXEL Industries SA (EPA:EXE) Worth Looking At Closely?

Apr 08
At €67.80, Is EXEL Industries SA (EPA:EXE) Worth Looking At Closely?

Calculating The Intrinsic Value Of Exel Industries Société Anonyme (EPA:EXE)

Mar 10
Calculating The Intrinsic Value Of Exel Industries Société Anonyme (EPA:EXE)

These Metrics Don't Make Exel Industries Société Anonyme (EPA:EXE) Look Too Strong

Feb 15
These Metrics Don't Make Exel Industries Société Anonyme (EPA:EXE) Look Too Strong

What Type Of Returns Would Exel Industries Société Anonyme's(EPA:EXE) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Jan 25
What Type Of Returns Would Exel Industries Société Anonyme's(EPA:EXE) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Previsiones de crecimiento de beneficios e ingresos

ENXTPA:EXE - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
9/30/20261,1725044753
9/30/20251,1204542694
9/30/20241,1114335674
3/31/20241,10443-320N/A
12/31/20231,099432952N/A
9/30/20231,094426283N/A
6/30/20231,074372851N/A
3/31/20231,05331-720N/A
12/31/20221,01530-38-11N/A
9/30/202297729-69-42N/A
6/30/202293830-26-4N/A
3/31/2022898311733N/A
12/31/2021888373248N/A
9/30/2021877434763N/A
6/30/2021851424458N/A
3/31/2021825404153N/A
12/31/2020790154253N/A
9/30/2020754-114354N/A
6/30/2020748-225163N/A
3/31/2020742-335872N/A
12/31/2019759-154456N/A
9/30/201977742940N/A
6/30/2019811201627N/A
3/31/201984536315N/A
12/31/201884238-511N/A
9/30/201883939-127N/A
6/30/201885240-417N/A
3/31/201886441427N/A
12/31/201786943N/A49N/A
9/30/201787445N/A70N/A
3/31/201776233N/AN/AN/A
12/31/201675932N/AN/AN/A
9/30/201675632N/A58N/A
2/29/201674442N/A35N/A
11/30/201573537N/A37N/A
8/31/201572532N/A39N/A
5/31/201572929N/A22N/A
2/28/201573227N/A6N/A
11/30/201475430N/A13N/A
8/31/201477534N/A21N/A
5/31/201477433N/A26N/A
2/28/201477232N/A32N/A
11/30/201375630N/A17N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (5.7% al año) de EXE es superior a la tasa de ahorro (1.2%).

Beneficios vs. Mercado: Se prevé que los beneficios (7.2% al año) de EXE crezcan menos que el mercado French (10.7% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de EXE crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (2.2% al año) de EXE crezcan más despacio que el mercado de French (5.8% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 2.2% al año) de EXE crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de EXE sea baja dentro de 3 años (9.2%).


Descubre empresas en crecimiento